Evidence for development of capillary leak syndrome associated with cardiopulmonary bypass in pediatric patients with the homozygous C4A null phenotype

Anesthesiology

Volumn 100, Issue 6, 2004, Pages 1387-1393

  Zhang, Shihai ^a   Wang, Shouyong ^a   Yao, Shanglong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EVANS BLUE; PROTAMINE; PROTEIN;

AGAROSE GEL IMMUNOFIXATION; ARTICLE; BIOCHEMISTRY; BIURET TEST; C4 GENE; C4A GENE; C4B GENE; CAPILLARY LEAK SYNDROME; CARDIOPULMONARY BYPASS; CHILD; CHILDHOOD DISEASE; COMPLEMENT ACTIVATION; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; GENE; GENE LOCUS; HOMOZYGOSITY; HUMAN; IMMUNOCHEMISTRY; IMMUNOELECTROPHORESIS; MAJOR CLINICAL STUDY; MALE; MEMBRANE STRUCTURE; NULL ALLELE; ONCOTIC PRESSURE; PHENOTYPE; PLASMA VOLUME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ANALYSIS OF VARIANCE; CAPILLARY LEAK SYNDROME; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; COMPLEMENT C4A; FEMALE; HOMOZYGOTE; HUMANS; MALE; PHENOTYPE;

EID: 2542479741     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200406000-00009     Document Type: Article

References (28)

1. Teelucksingh S, Padfield PL, Edwards CR: Systemic capillary leak syndrome. Q J Med 1990; 75:515-24
2. Elgebaly SA, Houser SL, el Kerm AF, Doyle K, Gillies C, Dalecki K: Evidence of cardiac inflammation after open heart operations. Ann Thorac Surg 1994; 57:391-6
3. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, Haverich A, Schlag G, Borst HG: Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61:1714-20
4. Kirklin JK, Blackstone EH, Kirklin JW: Cardiopulmonary bypass: Studies on its damaging effects. Blood Purif 1987; 5:168-78
5. Levy JH, Kelly AB: Inflammation and cardiopulmonary bypass. Can J Anaesth 1993; 40:1009-15
6. Prasad K, Kalra J, Bharadwaj B, Chaudhary A: Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am Heart J 1992; 123:37-45
7. Seghaye MC, Grabitz RG, Duchateau J, Busse S, Dabritz S, Koch D, Alzen G, Hornchen H, Messmer BJ, Von Bernuth G: Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg 1996; 112:687-97
8. Plotz FB, van Oeveren W, Bartlett RH, Wildevuur CR: Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg 1993; 105:823-32
9. Tassani P, Schad H, Winkler C, Bernhard A, Ettner U, Braun SL. Eising GP, Kochs E, Lange R, Richter JA: Capillary leak syndrome after cardiopulmonary bypass in elective, uncomplicated coronary artery bypass grafting operations: Does it exist? J Thorac Cardiovasc Surg 2002; 123:735-41
10. Awdeh ZL, Alper CA: Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A 1980; 77:3576-80
11. Law SKA, Dodds AW, Porter RR: A comparison of the properties of two classes, C4A and C4B, of the human complement C4. EMBO J 1984; 3:1819-23
12. Shastri KA, Logue GL, Stern MP, Rehman S, Raza S: Complement activation by heparin-protamine complexes during cardiopulmonary bypass: Effect of C4A null allele. J Thorac Cardiovasc Surg 1997; 114:482-8
13. Simpson J, Stephenson T: Regulation of extracellular fluid volume in neonates. Early Hum Dev 1993; 34:179-90
14. Maehara T, Novak I, Wyse RKH, Eliott MJ: Perioperative monitoring of total body water by bio-electrical impedance in children undergoing open-heart surgery. Eur J Cardiothorac Surg 1991; 5:258-65
15. Eising GP, Schad H, Heimisch W, Gippner-Steppert C, Jochum M, Braun SL, Mendler N, Meisner H, Lange R: Effect of cardiopulmonary bypass and hemofiltration on plasma cytokines and protein leakage in pigs. Thorac Cardiovasc Surg 2000; 48:86-92
16. Linderkamp O, Mader T, Butenandt O, Riegel KP: Plasma volume estimation in severely ill infants and children using a simplified Evans blue method. Eur J Pediatr 1977; 125:135-41
17. Wan S, LeClerc JL, Vincent JL: Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation. Ann Thorac Surg 1997; 63:269-76
18. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD: Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86:845-57
19. Kawamura T, Wakusawa R, Okada K, Inada S: Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukins 8 and 6 in reperfusion injury. Can J Anaesth 1993; 40:1016-21
20. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM: Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106:1008-16
21. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM: Cytokine balance and immunosuppressive changes at cardiac surgery: Contrasting response between patients and isolated CPB circuits. Br J Anaesth 1995; 75: 724-33
22. Kirklin JK, Chenoweth DE, Naftel DC, Blackstone EH, Kirklin JW, Bitran DD, Curd JG, Reves JG, Samuelson PN: Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg 1986; 41:193-9
23. Fiedel BA, Rent R, Myhrman R, Gewurz H: Complement activation by interaction of polyanions and polycations: II. Precipitation and role of IgG, C1q and C1-INH during heparin-protamine-induced consumption of complement. Immunology 1976; 30:161-9
24. Matis LA, Rollins SA: Complement-specific antibodies: Designing novel anti-inflammatories. Nat Med 1995; 1:839-42
25. Stehle G, Wunder A, Sinn H, Schrenk HH, Friedrich FA, Demple CE, Maier-Borst W, Heene DL: Complexes of a modified low-molecular-weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor medicated process in rats. J Surg Res 1995; 58:197-204
26. Ng YC, Peters DK, Walport MJ: Monoclonal rheumatoid factor-IgG immune complexes: Poor fixation of opsonic C4 and C3 despite efficient complement activation. Arthritis Rheum 1988; 31:99-107
27. Fitch JCK, Rollins S, Matis L, Alford B, Aranki S, Collard CD, Dewar M, Elefteriades J, Hines R, Kopf G, Kraker P, Li L, O'Hara R, Rinder C, Rinder H, Shaw R, Smith B, Stahl G, Shernan SK: Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 1999; 100:2499-506
28. Chenoweth DE, Cooper SW, Hugli TE, Stuart RW, Blackstone EH, Kirklin JW: Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304:497-503